Stryker (NYSE: SYK) revenue
Stryker reported revenue of $25,116m for fiscal 2025, 11.2% more than in fiscal 2024 ($22,595m). Since fiscal 2016 its revenue has grown by 121.8%, an average growth of 9.3% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $25,116m | +11.2% | $4,889m | 19.5% |
| 2024 | $22,595m | +10.2% | $3,689m | 16.3% |
| 2023 | $20,498m | +11.1% | $3,888m | 19.0% |
| 2022 | $18,449m | +7.8% | $2,841m | 15.4% |
| 2021 | $17,108m | +19.2% | $2,584m | 15.1% |
| 2020 | $14,351m | −3.6% | $2,223m | 15.5% |
| 2019 | $14,884m | +9.4% | $2,713m | 18.2% |
| 2018 | $13,601m | +9.3% | $2,537m | 18.7% |
| 2017 | $12,444m | +9.9% | $2,297m | 18.5% |
| 2016 | $11,325m | — | $2,175m | 19.2% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the revenue of Stryker
- How much revenue did Stryker make in fiscal 2025?
- Stryker reported revenue of $25,116m for fiscal 2025, compared with $22,595m in fiscal 2024.
- How much has the revenue of Stryker grown?
- Between fiscal 2016 and fiscal 2025 it went from $11,325m to $25,116m: 121.8% more, an average growth of 9.3% a year.
- What was the best year for revenue at Stryker?
- Of its last 10 fiscal years, fiscal 2025, with $25,116m.
- Where do the figures for Stryker come from?
- From the annual report (Form 10-K) that Stryker files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Stryker files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Stryker: the Stryker page · annual accounts · net income · dividends paid · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.